ACUMEN PHARMACEUTICALS INC's ticker is ABOS and the CUSIP is 00509G209. A total of 48 filers reported holding ACUMEN PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,180,861 | -13.7% | 3,417,075 | 0.0% | 4.20% | -13.7% |
| Q2 2023 | $16,436,131 | +18.5% | 3,417,075 | 0.0% | 4.86% | +41.8% |
| Q1 2023 | $13,873,325 | +75086.0% | 3,417,075 | 0.0% | 3.43% | -32.2% |
| Q4 2022 | $18,452 | -99.9% | 3,417,075 | 0.0% | 5.05% | -49.3% |
| Q3 2022 | $34,273,000 | +113.4% | 3,417,075 | 0.0% | 9.96% | +125.9% |
| Q2 2022 | $16,060,000 | +20.2% | 3,417,075 | 0.0% | 4.41% | +58.0% |
| Q1 2022 | $13,361,000 | -42.2% | 3,417,075 | 0.0% | 2.79% | -18.5% |
| Q4 2021 | $23,099,000 | -54.5% | 3,417,075 | 0.0% | 3.42% | -55.3% |
| Q3 2021 | $50,778,000 | – | 3,417,075 | – | 7.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sands Capital Ventures, LLC | 3,417,075 | $18,452 | 5.05% |
| Knollwood Investment Advisory, LLC | 1,678,510 | $9,063,954 | 3.55% |
| GUARDIAN POINT CAPITAL, LP | 300,000 | $1,620,000 | 1.28% |
| GREAT POINT PARTNERS LLC | 1,116,581 | $6,029,537 | 1.18% |
| RA Capital Management | 9,770,773 | $52,762,174 | 1.07% |
| Deep Track Capital, LP | 3,952,000 | $21,340,800 | 0.90% |
| Cheyne Capital Management (UK) LLP | 55,829 | $301,477 | 0.53% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 295,115 | $1,593,621 | 0.46% |
| COMMODORE CAPITAL LP | 498,315 | $2,691 | 0.41% |
| Ikarian Capital, LLC | 254,945 | $1,376,703 | 0.33% |